Prometheus is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care.
PROCLAIM(SM) Patient Registry Data Demonstrates Safety and Efficacy of Proleukin® (aldesleukin) When Sequenced with Immune ...
PROCLAIM Patient Registry Data Demonstrate Survival Benefit of First-line Proleukin® Therapy in Patients with Metastatic Re ...
New Data Show Proleukin® (aldesleukin) Improves Patient Outcomes as First-Line Therapy for the Treatment of Patients with M ...
PROCLAIMSM National Patient Registry Analysis Shows Improved Median Overall Survival in Patients with Metastatic Melanoma Treat ...